SCHEMBL23600334

SCHEMBL23600334

CC(C)Oc1ccc(OC2CCN(c3nc(=O)n(C)c4ccc(Cl)nc34)CC2)nc1

nearest known ligand 0.40

Predicted protein targets (top 6)

geneUniProtsupporting neighboursconfidence
▸ CHRM4 P08173 5/20 0.40
▸ DGKZ Q13574 8/20 0.38
▸ DGKA P23743 2/20 0.38
▸ ACACB O00763 4/20 0.37
▸ SCD O00767 2/20 0.36
▸ HRH3 Q9Y5N1 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23600283 0.88 DGKZ (0.51) DGKZDGKA
SCHEMBL23564413 0.85 DGKZ (0.39) DGKZDGKA
SCHEMBL23526928 0.85 DGKZ (0.39) DGKZDGKA
SCHEMBL30900944 0.85 DGKZ (0.39) DGKZDGKA
SCHEMBL23527170 0.80 DGKZ (0.45) DGKZDGKA
SCHEMBL23526848 0.77 DGKZ (0.49) DGKZDGKA
SCHEMBL23526997 0.77 DGKZ (0.49) DGKZDGKA
SCHEMBL23600178 0.77 DGKZ (0.49) DGKZDGKA
SCHEMBL23527091 0.77 DGKZ (0.49) DGKZDGKA
SCHEMBL23526924 0.77 DGKZ (0.49) DGKZDGKA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2021133750-A1 SUBSTITUTED BICYCLIC PIPERIDINE DERIVATIVES USEFUL AS T CELL ACTIVATORS BRISTOL-MYERS SQUIBB COMPANY (US) 2021-07-01 — — WO disclosed
Send feedback